Stay ADvised: Net Impression Matters—NAD, FTC, AGs, and NARB Turn Up the Heat

In This Issue: NARB Affirms NAD's Tru Niagen Decision, Reinforcing Scrutiny of Health Claims State AGs Weigh In on FTC's Food Delivery Fee Rulemaking Washington AG Targets Homeaglow's Discount Cleaning Offers and Review Practices NAD Schools Advertiser on Literally Truthful but Misleading Magnesium Claims Ninth Circuit: Lanham Act 'First to Market' Misrepresentation Not Actionable FTC Halts Data Broker Monetizing Highly Sensitive Geodata

Stay ADvised: Net Impression Matters—NAD, FTC, AGs, and NARB Turn Up the Heat. In April, we covered the National Advertising Division's (NAD) decision involving Tru Niagen, a nicotinamide riboside dietary supplement marketed to support nicotinamide adenine dinucleotide in oxidized form (NAD+) levels. The National Advertising Review Board (NARB) has now affirmed NAD's core recommendations, reinforcing that supplement advertisers cannot rely on 'cellular,' 'structure/function,' or mechanistic framing to avoid substantiating the broader health-benefit messages reasonably conveyed by the advertising. The challenged claims covered a wide range of health and performance messages, including heart health, brain health, immune health, muscle recovery, energy, metabolism, anti-aging, cellular repair, and time-to-improvement claims. NAD's central co...